Boundless Bio, Inc. Share Price

Equities

BOLD

US10170A1007

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 19/07/2024 BST 5-day change 1st Jan Change
3.56 USD -8.25% Intraday chart for Boundless Bio, Inc. -12.75% 0.00%
Sales 2024 * - Sales 2025 * - Capitalization 79.22M 6.13B
Net income 2024 * -69M -5.34B Net income 2025 * -96M -7.43B EV / Sales 2024 * -
Net cash position 2024 * 30.75M 2.38B Net cash position 2025 * 36.28M 2.81B EV / Sales 2025 * -
P/E ratio 2024 *
-0.47 x
P/E ratio 2025 *
-0.84 x
Employees 72
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.54%
More Fundamentals * Estimated data
Dynamic Chart
1 day-8.25%
1 week-12.75%
Current month-8.01%
1 month-35.27%
3 months-64.72%
More quotes
1 week
3.44
Extreme 3.44
4.49
1 month
3.44
Extreme 3.44
5.88
Current year
3.44
Extreme 3.44
15.24
1 year
3.44
Extreme 3.44
15.24
3 years
3.44
Extreme 3.44
15.24
5 years
3.44
Extreme 3.44
15.24
10 years
3.44
Extreme 3.44
15.24
More quotes
Date Price Change Volume
19/07/24 3.56 -8.25% 69,850
18/07/24 3.88 -7.18% 52,474
17/07/24 4.18 -2.56% 71,022
16/07/24 4.29 +1.90% 44,912
15/07/24 4.21 +3.19% 46,809

Delayed Quote Nasdaq, July 19, 2024 at 09:00 pm

More quotes
Boundless Bio Inc, formerly Pretzel Therapeutics Inc, is a United States-based precision oncology company. The Company is focused on developing therapeutics directed against extrachromosomal DNA (ecDNA) to deliver transformative therapies to patients with previously intractable cancers.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.56 USD
Average target price
23 USD
Spread / Average Target
+546.07%
Consensus